Creteil, France

Gerard Taurand


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 32(Granted Patents)


Location History:

  • Sucy-en-Brie, FR (1983)
  • Creteil, FR (1986 - 1994)

Company Filing History:


Years Active: 1983-1994

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Gerard Taurand: Innovator in Pharmaceutical Chemistry

Introduction

Gerard Taurand is a notable inventor based in Creteil, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on phenothiazine derivatives. With a total of 10 patents to his name, Taurand's innovations have had a considerable impact on the development of analgesic and diuretic medications.

Latest Patents

Among his latest patents are the phenothiazine derivatives, which include their preparation and pharmaceutical applications. These new phenothiazine derivatives are characterized by a general formula (I), where R represents a linear or branched (1 to 6 C) alkyl radical. Additionally, R1 and R2 can be linear or branched (1 to 4 C) alkyl radicals or can form, with the nitrogen atom to which they are attached, a 4- to 7-membered heterocycle. The isomeric forms and mixtures of these compounds, along with their addition salts with acids, exhibit both analgesic and diuretic activity.

Career Highlights

Throughout his career, Gerard Taurand has worked with prominent companies in the pharmaceutical industry, including Rhone-Poulenc Santé. His expertise in the field has allowed him to develop innovative solutions that address various medical needs.

Collaborations

Taurand has collaborated with esteemed colleagues such as Claude Guyon and Claude Cotrel. These partnerships have further enhanced his research and development efforts in pharmaceutical chemistry.

Conclusion

Gerard Taurand's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medication development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…